(Q45148210)

10 December 2017

title

Atorvastatin reduces remnant lipoproteins and small, dense low-density lipoproteins regardless of the baseline lipid pattern (English)

1 reference

10 December 2017

James H O'Keefe

1

1 reference

10 December 2017

Becky K Captain

series ordinal

2

1 reference

10 December 2017

Philip G Jones

series ordinal

3

1 reference

10 December 2017

William S Harris

series ordinal

4

1 reference

10 December 2017

publication date

1 January 2004

1 reference

10 December 2017

published in

Preventive Cardiology

1 reference

10 December 2017

volume

7

1 reference

10 December 2017

issue

4

1 reference

10 December 2017

page(s)

154-160

1 reference

Postprandial lipemia and cardiovascular disease

10 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1520-037X.2004.03594.X

Comparison of remnant-like lipoprotein particles in postmenopausal women with and without coronary artery disease and in men with coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1520-037X.2004.03594.X

Remnant lipoprotein levels in fasting serum predict coronary events in patients with coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1520-037X.2004.03594.X

Intermediate-density lipoproteins and progression of carotid arterial wall intima-media thickness

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1520-037X.2004.03594.X

Glyceride–glycerol release and the interconversion of glucose and glycerol in normal and fasted rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1520-037X.2004.03594.X

Atherogenic lipoprotein phenotype. A proposed genetic marker for coronary heart disease risk.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1520-037X.2004.03594.X

Low density lipoprotein particle size and risk of early-onset myocardial infarction in women

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1520-037X.2004.03594.X

Predominance of dense low-density lipoprotein particles predicts angiographic benefit of therapy in the Stanford Coronary Risk Intervention Project

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1520-037X.2004.03594.X

Smallest LDL particles are most strongly related to coronary disease progression in men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1520-037X.2004.03594.X

Relationships between low-density lipoprotein particle size, plasma lipoproteins, and progression of coronary artery disease: the Diabetes Atherosclerosis Intervention Study (DAIS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1520-037X.2004.03594.X

Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial--Lipid Lowering Arm (ASCOT-LLA): a multicentre ra

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1520-037X.2004.03594.X

Aggressive lipid-lowering therapy compared with angioplasty in stable coronary artery disease. Atorvastatin versus Revascularization Treatment Investigators.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1520-037X.2004.03594.X

Effect of aggressive versus conventional lipid lowering on atherosclerosis progression in familial hypercholesterolaemia (ASAP): a prospective, randomised, double-blind trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1520-037X.2004.03594.X

Small dense LDL phenotype is associated with postprandial increases of large VLDL and remnant-like particles in patients with acute myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1520-037X.2004.03594.X

Impact of postprandial variation in triglyceridemia on low-density lipoprotein particle size

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1520-037X.2004.03594.X

Associations of LDL size with in vitro oxidizability and plasma levels of in vivo oxidized LDL in Type 2 diabetic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1520-037X.2004.03594.X

Relations Between Plasma Lipids and Postheparin Plasma Lipases and VLDL and LDL Subfraction Patterns in Normolipemic Men and Women

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1520-037X.2004.03594.X

Inflammatory Reactions in the Pathogenesis of Atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1520-037X.2004.03594.X

Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1520-037X.2004.03594.X

MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1520-037X.2004.03594.X

Comparisons of effects of statins (atorvastatin, fluvastatin, lovastatin, pravastatin, and simvastatin) on fasting and postprandial lipoproteins in patients with coronary heart disease versus control subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1520-037X.2004.03594.X

The effects of atorvastatin on endothelial function in diabetic patients and subjects at risk for type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1520-037X.2004.03594.X

Comparison of the efficacy and safety of rosuvastatin versus atorvastatin, simvastatin, and pravastatin across doses (STELLAR* Trial).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1520-037X.2004.03594.X

Postprandial lipoproteins and progression of coronary atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1520-037X.2004.03594.X

10.1111/J.1520-037X.2004.03594.X

21 January 2018

Identifiers

DOI

1 reference

10 December 2017

1 reference